JCL Roundtable. Obesity, Diabetes, and Liver Disease in Relation to Cardiovascular Risk
Metabolic risk for cardiovascular and other systems includes much more than just LDL cholesterol. This JCL Roundtable brings together 3 experts to address new opportunities to reduce the risks posed by obesity, diabetes, and fatty liver disease. Successful nutritional approaches to weight loss are diverse and need to be matched with individual preferences. Topiramate plus extended-release phentermine has been shown to promote meaningful weight loss in randomized trials, but the patented drug combination is expensive.
Source: Journal of Clinical Lipidology - Category: Lipidology Authors: Kathleen L. Wyne, Sheldon E. Litwin, Kenneth Cusi, John R. Guyton Source Type: research
More News: Adipex | Cardiology | Cardiovascular | Cholesterol | Diabetes | Eating Disorders & Weight Management | Endocrinology | Fatty Liver Disease (FLD) | Heart | Lipidology | Liver | Liver Disease | Nutrition | Obesity | Phentermine | Topamax | Urology & Nephrology | Weight Loss